ARTICLE | Company News
SemBioSys endocrine, cardiovascular news
October 11, 2010 7:00 AM UTC
SemBioSys hired Deloitte to explore strategic alternatives, including a sale or merger, partnering or selling its assets, a refinancing in conjunction with a significant restructuring, or a wind down ...